CA2360852A1 - Produit que l'on peut fumer - Google Patents
Produit que l'on peut fumer Download PDFInfo
- Publication number
- CA2360852A1 CA2360852A1 CA002360852A CA2360852A CA2360852A1 CA 2360852 A1 CA2360852 A1 CA 2360852A1 CA 002360852 A CA002360852 A CA 002360852A CA 2360852 A CA2360852 A CA 2360852A CA 2360852 A1 CA2360852 A1 CA 2360852A1
- Authority
- CA
- Canada
- Prior art keywords
- filter
- tobacco
- product according
- strand
- smokable product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 235000019504 cigarettes Nutrition 0.000 claims abstract description 137
- 239000000126 substance Substances 0.000 claims abstract description 64
- 239000000779 smoke Substances 0.000 claims abstract description 47
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 44
- 235000019506 cigar Nutrition 0.000 claims abstract description 11
- 241000208125 Nicotiana Species 0.000 claims description 147
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 147
- 239000000463 material Substances 0.000 claims description 54
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 37
- 229940042585 tocopherol acetate Drugs 0.000 claims description 37
- 239000003610 charcoal Substances 0.000 claims description 31
- 238000007792 addition Methods 0.000 claims description 30
- 230000035699 permeability Effects 0.000 claims description 28
- 238000009423 ventilation Methods 0.000 claims description 26
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 22
- 230000004089 microcirculation Effects 0.000 claims description 21
- 239000002245 particle Substances 0.000 claims description 20
- 239000011888 foil Substances 0.000 claims description 15
- 239000000654 additive Substances 0.000 claims description 14
- 239000004148 curcumin Substances 0.000 claims description 11
- 235000012754 curcumin Nutrition 0.000 claims description 11
- 229940109262 curcumin Drugs 0.000 claims description 11
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- 229920002301 cellulose acetate Polymers 0.000 claims description 10
- 230000009467 reduction Effects 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 8
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 7
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 6
- 230000006735 deficit Effects 0.000 claims description 6
- ATJVZXXHKSYELS-FNORWQNLSA-N ethyl (e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(O)C(OC)=C1 ATJVZXXHKSYELS-FNORWQNLSA-N 0.000 claims description 6
- 125000004494 ethyl ester group Chemical group 0.000 claims description 6
- ATJVZXXHKSYELS-UHFFFAOYSA-N ferulic acid ethyl ester Natural products CCOC(=O)C=CC1=CC=C(O)C(OC)=C1 ATJVZXXHKSYELS-UHFFFAOYSA-N 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 239000004113 Sepiolite Substances 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims description 4
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 claims description 4
- 229910052624 sepiolite Inorganic materials 0.000 claims description 4
- 235000019355 sepiolite Nutrition 0.000 claims description 4
- AUJXJFHANFIVKH-GQCTYLIASA-N trans-methylferulate Chemical compound COC(=O)\C=C\C1=CC=C(O)C(OC)=C1 AUJXJFHANFIVKH-GQCTYLIASA-N 0.000 claims description 4
- -1 aluminas Substances 0.000 claims description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 235000010384 tocopherol Nutrition 0.000 claims description 3
- 229960001295 tocopherol Drugs 0.000 claims description 3
- 229930003799 tocopherol Natural products 0.000 claims description 3
- 239000011732 tocopherol Substances 0.000 claims description 3
- 239000010457 zeolite Substances 0.000 claims description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 2
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 claims description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 2
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 claims description 2
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 claims description 2
- 239000005770 Eugenol Substances 0.000 claims description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims description 2
- HMKKIXGYKWDQSV-KAMYIIQDSA-N alpha-Amylcinnamaldehyde Chemical compound CCCCC\C(C=O)=C\C1=CC=CC=C1 HMKKIXGYKWDQSV-KAMYIIQDSA-N 0.000 claims description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 2
- 229910021502 aluminium hydroxide Inorganic materials 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 239000000440 bentonite Substances 0.000 claims description 2
- 229910000278 bentonite Inorganic materials 0.000 claims description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 2
- 235000017803 cinnamon Nutrition 0.000 claims description 2
- 235000020230 cinnamon extract Nutrition 0.000 claims description 2
- 229940099418 d- alpha-tocopherol succinate Drugs 0.000 claims description 2
- 229960002217 eugenol Drugs 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- AUJXJFHANFIVKH-UHFFFAOYSA-N methyl cis-ferulate Natural products COC(=O)C=CC1=CC=C(O)C(OC)=C1 AUJXJFHANFIVKH-UHFFFAOYSA-N 0.000 claims description 2
- 150000004702 methyl esters Chemical class 0.000 claims description 2
- 239000002808 molecular sieve Substances 0.000 claims description 2
- 239000002243 precursor Substances 0.000 claims description 2
- 229960003471 retinol Drugs 0.000 claims description 2
- 235000020944 retinol Nutrition 0.000 claims description 2
- 239000011607 retinol Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 claims description 2
- 239000000741 silica gel Substances 0.000 claims description 2
- 229910002027 silica gel Inorganic materials 0.000 claims description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 2
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 claims description 2
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 claims description 2
- 229960000984 tocofersolan Drugs 0.000 claims 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims 1
- 239000013543 active substance Substances 0.000 abstract description 3
- 239000007792 gaseous phase Substances 0.000 abstract 3
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 239000007789 gas Substances 0.000 description 51
- 239000000203 mixture Substances 0.000 description 31
- 238000012360 testing method Methods 0.000 description 28
- 210000001519 tissue Anatomy 0.000 description 19
- 230000000391 smoking effect Effects 0.000 description 18
- 238000005259 measurement Methods 0.000 description 17
- 210000000265 leukocyte Anatomy 0.000 description 14
- 238000011835 investigation Methods 0.000 description 12
- 238000000034 method Methods 0.000 description 11
- 210000000601 blood cell Anatomy 0.000 description 9
- 235000019640 taste Nutrition 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 210000004088 microvessel Anatomy 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000007717 exclusion Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 238000012771 intravital microscopy Methods 0.000 description 6
- 101000968267 Drosophila melanogaster Protein dachsous Proteins 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000004400 mucous membrane Anatomy 0.000 description 5
- 230000002411 adverse Effects 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 230000008105 immune reaction Effects 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 235000019505 tobacco product Nutrition 0.000 description 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 2
- 241001479434 Agfa Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 229960002715 nicotine Drugs 0.000 description 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 2
- 229940037201 oris Drugs 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000008844 regulatory mechanism Effects 0.000 description 2
- 230000036387 respiratory rate Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 238000000585 Mann–Whitney U test Methods 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 238000001793 Wilcoxon signed-rank test Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 206010001584 alcohol abuse Diseases 0.000 description 1
- 208000025746 alcohol use disease Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 210000002565 arteriole Anatomy 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000021443 coca cola Nutrition 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000004513 dentition Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000005977 kidney dysfunction Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 231100000243 mutagenic effect Toxicity 0.000 description 1
- 231100000299 mutagenicity Toxicity 0.000 description 1
- 230000007886 mutagenicity Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000010517 secondary reaction Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000036346 tooth eruption Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 235000018648 unbalanced nutrition Nutrition 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
- A24B15/303—Plant extracts other than tobacco
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/308—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances vitamins
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/06—Use of materials for tobacco smoke filters
- A24D3/16—Use of materials for tobacco smoke filters of inorganic materials
- A24D3/163—Carbon
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P70/00—Climate change mitigation technologies in the production process for final industrial or consumer products
- Y02P70/50—Manufacturing or production processes characterised by the final manufactured product
Landscapes
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Cigarettes, Filters, And Manufacturing Of Filters (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Cette invention concerne des produits que l'on peut fumer, tels que des cigarettes avec filtre, des cigarillos avec filtre ou des cigares pourvus d'un filtre. Ces produits contiennent des substances actives antioxydantes supplémentaires et possèdent un filtre actif vis-à-vis de la phase gazeuse et/ou du papier à cigarettes actif vis-à-vis de la phase gazeuse et/ou un ou plusieurs autres composants laissant passer le flux principal de fumée et contenant des substances actives vis-à-vis de la phase gazeuse supplémentaires.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP1999/001263 WO2000049901A2 (fr) | 1999-02-26 | 1999-02-26 | Produit que l'on peut fumer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2360852A1 true CA2360852A1 (fr) | 2000-08-31 |
Family
ID=8167226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002360852A Abandoned CA2360852A1 (fr) | 1999-02-26 | 1999-02-26 | Produit que l'on peut fumer |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1178741A2 (fr) |
| JP (1) | JP2003500008A (fr) |
| KR (1) | KR20010108248A (fr) |
| AU (1) | AU3030799A (fr) |
| BG (1) | BG105844A (fr) |
| CA (1) | CA2360852A1 (fr) |
| CZ (1) | CZ20012899A3 (fr) |
| EA (1) | EA200100917A1 (fr) |
| EE (1) | EE200100445A (fr) |
| HR (1) | HRP20010596A2 (fr) |
| HU (1) | HUP0203227A3 (fr) |
| IL (1) | IL144252A0 (fr) |
| IS (1) | IS6059A (fr) |
| NO (1) | NO20014133L (fr) |
| PL (1) | PL353568A1 (fr) |
| SK (1) | SK12032001A3 (fr) |
| TR (1) | TR200102488T2 (fr) |
| TW (1) | TW480157B (fr) |
| WO (1) | WO2000049901A2 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006133491A1 (fr) * | 2005-06-14 | 2006-12-21 | Exnox Technologies Limited | Capture de toxines et de polluants provenant de l'environnement |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100381082C (zh) * | 2003-03-14 | 2008-04-16 | 韩力 | 一种非可燃性电子雾化香烟 |
| CN100381083C (zh) * | 2003-04-29 | 2008-04-16 | 韩力 | 一种非可燃性电子喷雾香烟 |
| CN2719043Y (zh) | 2004-04-14 | 2005-08-24 | 韩力 | 雾化电子烟 |
| DE102005005175A1 (de) | 2005-02-01 | 2006-08-10 | Reemtsma Cigarettenfabriken Gmbh | Filtercigarette |
| KR100676149B1 (ko) * | 2005-06-24 | 2007-02-01 | 한현수 | 흡연 여과용 촉매 여과물질, 이를 포함하는 담배필터, 담배및 끽연용구 |
| CN201067079Y (zh) | 2006-05-16 | 2008-06-04 | 韩力 | 仿真气溶胶吸入器 |
| RU2328191C1 (ru) * | 2006-12-12 | 2008-07-10 | Олег Иванович Квасенков | Способ получения легкого кретека |
| CN201379072Y (zh) | 2009-02-11 | 2010-01-13 | 韩力 | 一种改进的雾化电子烟 |
| EP2683431B1 (fr) | 2011-03-09 | 2017-01-18 | Chong Corporation | Système d'administration de médicament |
| US8903228B2 (en) | 2011-03-09 | 2014-12-02 | Chong Corporation | Vapor delivery devices and methods |
| US9399110B2 (en) | 2011-03-09 | 2016-07-26 | Chong Corporation | Medicant delivery system |
| EP2606751A1 (fr) * | 2011-12-21 | 2013-06-26 | Reemtsma Cigarettenfabriken GmbH | Article contenant du tabac |
| CN103099307A (zh) * | 2012-11-13 | 2013-05-15 | 苏州谷力生物科技有限公司 | 一种添加活性炭薄片卷烟的制备方法 |
| WO2018045174A1 (fr) * | 2016-08-31 | 2018-03-08 | Baybutt Richard | Composition et son utilisation |
| KR102450712B1 (ko) * | 2019-12-16 | 2022-10-04 | 주식회사 케이티앤지 | 소리가 발생되는 흡연 물품 |
| KR102450713B1 (ko) * | 2019-12-16 | 2022-10-04 | 주식회사 케이티앤지 | 소리가 발생되는 흡연 물품 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE416101C (de) | 1923-04-09 | 1925-07-09 | Octave Harmel | Maschine zum Spalten von Holz, insbesondere Brennholz |
| US4805644A (en) | 1986-06-30 | 1989-02-21 | Kimberly-Clark Corporation | Sidestream reducing cigarette paper |
| US4804002A (en) | 1987-05-29 | 1989-02-14 | P. H. Glatfelter Company | Tobacco product containing side stream smoke flavorant |
| US4915118A (en) | 1988-04-20 | 1990-04-10 | P. H. Glatfelter Company | Smoking article wrapper and method of making same |
| DE3840329A1 (de) | 1988-11-30 | 1990-06-07 | Glatz Julius Gmbh | Umhuellung fuer raucherartikel |
| US5365951A (en) * | 1990-08-24 | 1994-11-22 | Philip Morris Incorporated | Concentric smoking filter having cellulose acetate tow periphery and carbon-particle-loaded web filter core |
| DE4105500C1 (fr) | 1991-02-19 | 1992-06-17 | H.F. & Ph.F. Reemtsma Gmbh & Co, 2000 Hamburg, De | |
| DE4205658A1 (de) * | 1992-02-25 | 1993-08-26 | Reemtsma H F & Ph | Ventilierte filtercigarette |
| DE4244467C2 (de) | 1992-12-24 | 1996-11-14 | Reemtsma H F & Ph | Cigarette |
| US5404890A (en) * | 1993-06-11 | 1995-04-11 | R. J. Reynolds Tobacco Company | Cigarette filter |
| DE4416101C2 (de) * | 1994-04-19 | 1997-06-12 | Reemtsma H F & Ph | Tabakerzeugnisse oder Tabakerzeugnissen ähnliche Waren mit antioxidativ wirkenden Naturstoffen und Verfahren zur Herstellung derselben |
| DE19753195A1 (de) | 1997-11-21 | 1999-05-27 | Reemtsma H F & Ph | Biologisch abbaubarer Filter für Cigaretten |
| DE19753193A1 (de) | 1997-11-21 | 1999-05-27 | Reemtsma H F & Ph | Biologisch abbaubarer Filter für Cigaretten |
-
1999
- 1999-02-26 HR HR20010596A patent/HRP20010596A2/hr not_active Application Discontinuation
- 1999-02-26 CZ CZ20012899A patent/CZ20012899A3/cs unknown
- 1999-02-26 KR KR1020017010705A patent/KR20010108248A/ko not_active Withdrawn
- 1999-02-26 WO PCT/EP1999/001263 patent/WO2000049901A2/fr not_active Ceased
- 1999-02-26 IL IL14425299A patent/IL144252A0/xx unknown
- 1999-02-26 JP JP2000600518A patent/JP2003500008A/ja active Pending
- 1999-02-26 EA EA200100917A patent/EA200100917A1/ru unknown
- 1999-02-26 EP EP99911715A patent/EP1178741A2/fr not_active Withdrawn
- 1999-02-26 SK SK1203-2001A patent/SK12032001A3/sk unknown
- 1999-02-26 PL PL99353568A patent/PL353568A1/xx unknown
- 1999-02-26 EE EEP200100445A patent/EE200100445A/xx unknown
- 1999-02-26 TR TR2001/02488T patent/TR200102488T2/xx unknown
- 1999-02-26 HU HU0203227A patent/HUP0203227A3/hu unknown
- 1999-02-26 CA CA002360852A patent/CA2360852A1/fr not_active Abandoned
- 1999-02-26 AU AU30307/99A patent/AU3030799A/en not_active Abandoned
- 1999-07-27 TW TW088112688A patent/TW480157B/zh not_active IP Right Cessation
- 1999-08-22 IS IS6059A patent/IS6059A/is unknown
-
2001
- 2001-08-24 NO NO20014133A patent/NO20014133L/no not_active Application Discontinuation
- 2001-08-24 BG BG105844A patent/BG105844A/bg unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006133491A1 (fr) * | 2005-06-14 | 2006-12-21 | Exnox Technologies Limited | Capture de toxines et de polluants provenant de l'environnement |
Also Published As
| Publication number | Publication date |
|---|---|
| EE200100445A (et) | 2002-12-16 |
| NO20014133L (no) | 2001-10-22 |
| HUP0203227A2 (hu) | 2003-01-28 |
| CZ20012899A3 (cs) | 2002-07-17 |
| TW480157B (en) | 2002-03-21 |
| IL144252A0 (en) | 2002-05-23 |
| SK12032001A3 (sk) | 2002-01-07 |
| HUP0203227A3 (en) | 2003-02-28 |
| WO2000049901A3 (fr) | 2002-07-11 |
| TR200102488T2 (tr) | 2002-11-21 |
| JP2003500008A (ja) | 2003-01-07 |
| IS6059A (is) | 2000-08-27 |
| EP1178741A2 (fr) | 2002-02-13 |
| WO2000049901A2 (fr) | 2000-08-31 |
| PL353568A1 (en) | 2003-12-01 |
| HRP20010596A2 (en) | 2002-08-31 |
| KR20010108248A (ko) | 2001-12-07 |
| EA200100917A1 (ru) | 2002-08-29 |
| BG105844A (bg) | 2002-04-30 |
| AU3030799A (en) | 2000-09-14 |
| NO20014133D0 (no) | 2001-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2360852A1 (fr) | Produit que l'on peut fumer | |
| Matthys et al. | Dextromethorphan and codeine: objective assessment of antitussive activity in patients with chronic cough | |
| Frederiksen et al. | Carbon monoxide and smoking behavior | |
| KR100370340B1 (ko) | 담배 대용 조성물 | |
| US4596258A (en) | Smoking devices | |
| WO2006070288A2 (fr) | Generateur d'aerosol | |
| EA002711B1 (ru) | Табачные изделия с витамином е | |
| Tashkin et al. | Effects of varying marijuana smoking profile on deposition of tar and absorption of CO and delta-9-THC | |
| Turner et al. | Some effects of changing to low-tar and low-nicotine cigarettes | |
| Hollister | Tetrahydrocannabinol isomers and homologues: contrasted effects of smoking | |
| Russell et al. | Blood nicotine and carboxyhemoglobin levels after rapid-smoking aversion therapy. | |
| WO1989006912A1 (fr) | Procede de fabrication de cigarettes utilisant des alcools preselectionnes | |
| US4967772A (en) | Tobacco smoking article and treatment of tobacco smoke with at least one alcohol | |
| EP4241768A1 (fr) | Composition pour le traitement d'une maladie vasculaire, composition pour la prévention d'une maladie vasculaire, composition pour le traitement de l'hypertension et composition pour la prévention de l'hypertension | |
| Dixon | The tobacco habit | |
| WO1996027303A1 (fr) | Article pour fumeurs exempt de nicotine | |
| US20030131858A1 (en) | Smoking artifact | |
| Keen et al. | Decline of tissue noradrenaline under the influence of a mitotic inhibitor | |
| EP0450253B1 (fr) | Moyen pour se désaccoutumer du tabac | |
| Howe et al. | Acute heroin abstinence in man: II. Alterations in rapid eye movement (REM) sleep | |
| US3862317A (en) | Reducing dependence on tobacco | |
| Pihl et al. | The effect of marihuana intoxication on blood pressure | |
| Dixon | THE TWELFTH NORMAN KERR MEMORIAL LECTURE: 1927.* THE TOBACCO HABIT | |
| Fincham | The etiology and pathogenesis of detrimental health effects in elderly smokers. | |
| WO1989001301A1 (fr) | Article permettant de fumer du tabac |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |